• Clinical Trials

  • The Penrose Cancer Center has been involved in cancer prevention and treatment clinical trials for more than 30 years. Since 1992, the Penrose Cancer Center has been part of the Colorado Cancer Research Program (CCRP). The National Cancer Institute provides some funding, which allows us to offer national cooperative group studies. The CCRP is designated as a Community Clinical Oncology Program by the National Cancer Institute. In addition to our affiliation with the CCRP, we joined the Radiation Therapy Oncology Group (RTOG) in 2007, the Center for Clinical Trials (CCT) through Catholic Health Initiatives (CHI) in 2008, and we are now working with Accuray and Georgetown University Medical Center on CyberKnife® studies.  

    The NCI Community Cancer Centers Program contract has provided us with the additional staff necessary to adequately provide for our research patients. In 2009, the highly skilled research nurses at Penrose Cancer Center enrolled 95 patients into research studies. By 2010, that number had increased to 217 patients.

    Penrose Cancer Center participates in several important registry projects to collect data for researchers.  Among these projects are the Eppley Breast Registry, a repository for social, demographic, environmental, clinical and family history on patients with precancerous and cancerous breast disease developed by the University of Nebraska Medical Center. Another is the ReCKord CyberKnife® registry, an international registry database designed to track CyberKnife® System utilization, practices and outcomes in the treatment of cancers and benign tumors. 

    We have also recently signed a contract to work with The Center for Translational Research (CTR). This is a biospecimen banking repository and we will be developing physician initiated studies through this group.

    Current Clinical Trials available at the Penrose Cancer Center through CCRP. Non-CCRP Available Protocols (as of December 2013).

Search: Current Site All Sites